| Literature DB >> 24303117 |
Aurélien Pichon1, Bai Zhenzhong, Dominique Marchant, Guoen Jin, Nicolas Voituron, Yun Haixia, Fabrice Favret, Jean-Paul Richalet, Ri-Li Ge.
Abstract
The aim of this study was to assess maximal heart rate (HR) and heart morphological changes in high altitude living "plateau pikas" and rats bred at 2260 m. Rats and pikas were catheterized to measure HR (2260 m). After baseline measurements, 1 mg/kg of atropine (AT) and increasing doses of isoproterenol (IsoP) (0.1, 1, 10, and 100 μg kg) were injected into animals. Right (RV) and left ventricles (LV) were removed to calculate Fulton's ratio (LV + septum (S) to RV weights) and to assess mRNA expression level of β1- and β2-adrenoceptors, muscarinic m1 and m2 receptors, and vascular endothelial growth factor (VEGF). Resting HR was significantly lower in rats than in pikas and increased after AT injection only in rats. IsoP injection induced a significant increase in HR in rat for all doses, which was systematically greater than in pikas. In pikas HR was slightly increased only after the two highest concentrations of IsoP. Fulton's ratio was greater in rats compared with pikas but the LV + S adjusted for body weight was greater in pikas. Pikas showed lower β1-adrenoceptors and muscarinic m2 receptors mRNA expression but larger VEGF mRNA expression than rats both in RV and LV. These results suggest that pikas have a lower maximal HR compared with rats certainly due to a decrease in β-adrenergic and muscarinic receptors mRNA expression. However, the LV hypertrophy probably led to an increase in stroke volume to maintain cardiac output in response to the cold and hypoxic environment.Entities:
Keywords: Atropine; high altitude adaptation; hypoxia; isoproterenol; muscarinic receptors; ventricle hypertrophy; β-adrenergic receptors
Year: 2013 PMID: 24303117 PMCID: PMC3831927 DOI: 10.1002/phy2.32
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Sequences of primer used for biological analysis of rats and pikas hearts obtained by multiple alignments of homologous sequences of at least five different species
| Gene | Primer sequence | Predicted PCR product size | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 18S ribosomal RNA | Forward primer | 5′ | AGG | CCA | TGA | TTA | AGA | GGG | AC | 3′ | 153 bp |
| Reverse primer | 5′ | TCT | GAT | CGT | CGT | CGA | ACC | TC | 3′ | ||
| β1-adrenoceptor | Forward primer | 5′ | TGT | GCA | TCA | TGG | CCT | TCG | T | 3′ | ∼392 bp |
| Reverse primer | 5′ | GCA | GTA | GAT | GAT | GGG | GTT | GA | 3′ | ||
| β2-adrenoceptor | Forward primer | 5′ | TGC | TGA | CCA | AGA | ATA | AGG | CC | 3′ | ∼427 bp |
| Reverse primer | 5′ | AGG | GTG | AAR | GTG | CCC | ATG | AT | 3′ | ||
| Muscarinic m2 receptor | Forward primer | 5′ | TGT | TCA | GCT | TGG | CCT | GTG | CT | 3′ | ∼250 bp |
| Reverse primer | 5′ | GCA | ATC | ATC | ATR | CCT | GCC | AT | 3′ | ||
| VEGF 189 | Forward primer | 5′ | CCC | ATG | AAG | TGG | TGA | AGT | TC | 3′ | ∼253 bp |
| Reverse primer | 5′ | CTC | ATC | TCT | CCT | ATG | TGC | TG | 3′ | ||
For VEGF gene sequence was available in database (EU262734).
PCR conditions optimized for interest genes coamplified with 18S ribosomal RNA
| PCR | Primer concentration | Initial denaturation | Number of cycles | Denaturation | Annealing | Extension | Final extension |
|---|---|---|---|---|---|---|---|
| β1-adrenoceptor /18S ribosomal RNA | 40 μmol/L 10 μmol/L | 94°C 10 min | 36 | 94°C 2 min 15 sec | 50°C 45 sec | 72°C 30 sec | 72°C 7 min |
| β2-adrenoceptor /18S ribosomal RNA | 13 μmol/L 20 μmol/L | 94°C 5 min | 35 | 94°C 1 min | 55°C 1 min | 72°C 1 min | 72°C 7 min |
| Muscarinic m2 receptor /18S ribosomal RNA | 21 μmol/L 17 μmol/L | 94°C 5 min | 33 | 94°C 1 min | 56°C 1 min | 72°C 1 min | 72°C 7 min |
| VEGF 189 /18S ribosomal RNA | 27 μmol/L 10 μmol/L | 94°C 5 min | 32 | 94°C 1 min | 58°C 1 min | 72°C 1 min | 72°C 7 min |
Animal characteristics and heart ventricles weight in absolute values and relative to body weight
| Body weight (g) | RV weight (mg) | LV + S weight (mg) | RV/BW (mg/g) | LV + S/BW (mg/g) | Fulton ratio | PAP (mmHg) | |
|---|---|---|---|---|---|---|---|
| Rats | 348 ± 36 | 306.2 ± 36.2 | 717.0 ± 112.7 | 0.90 ± 0.23 | 2.05 ± 0.19 | 0.44 ± 0.13 | 21.8 ± 5.0 |
| Pikas | 133 ± 11 | 88.4 ± 19.0 | 375.9 ± 50.1 | 0.67 ± 0.15 | 2.84 ± 0.34 | 0.23 ± 0.03 | 13.3 ± 0.5 |
Values are mean ± SD. RV, right ventricle; LV + S, left ventricle + septum; BW, body weight; PAP, pulmonary arterial pressure.
P < 0.05 pikas versus rats.
Figure 1Baseline heart rate and heart rate response to a single dose of atropine (AT, 1 mg/kg) in rats and Plateau pikas. Values are mean ± SD. *, significantly different from baseline value (P < 0.05). °, significantly different from pikas value (P < 0.05).
Figure 2Heart rate changes after atropine injection (AT, 1 mg/kg) according to increasing doses of isoproterenol (IsoP – 0.1, 1, 10, and 100 μg/kg). Values are mean ± SD. *, significantly different from AT values (P < 0.05). °, significantly different from pikas value (P < 0.05).
mRNA expression level of β1- and β2-adrenoceptors, muscarinic m2 receptors, and vascular endothelial growth factor (VEGF) expressed in relative values compared with the housekeeping gene (18S rRNA)
| Ventricle | β1-adrenoceptors | β2-adrenoceptors | β1/β2-adrenoceptors | m2 receptors | VEGF | |
|---|---|---|---|---|---|---|
| Rats | Left | 0.68 ± 0.27 | 0.58 ± 0.07 | 1.24 ± 0.59 | 1.08 ± 0.06 | 1.54 ± 0.18 |
| Right | 0.57 ± 0.14 | 0.88 ± 0.21 | 0.57 ± 0.23 | 1.143 ± 0.35 | 1.66 ± 0.19 | |
| Pikas | Left | 0.31 ± 0.09 | 1.26 ± 0.22 | 0.25 ± 0.09 | 0.26 ± 0.11 | 2.42 ± 0.22 |
| Right | 0.08 ± 0.10 | 1.53 ± 0.22 | 0.05 ± 0.07 | 0.46 ± 0.19 | 2.43 ± 0.33 |
Values are mean ± SD.
P < 0.05 pikas versus rats.
Figure 3Correlations between mRNA expression and changes in heart rate (HR) after atropine (1 mg/kg) or isoproterenol (IsoP) injection (100 μg/kg) in the left ventricle of the heart Plateau Pikas and rats. Panel A. correlation between HR after atropine injection and muscarinic m2 receptor mRNA expression; Panel B. correlation between HR after IsoP injection and β1-adrenoceptor mRNA expression; Panel C. correlation between HR after IsoP injection and β2-adrenoceptor mRNA expression; Panel D. correlation between HR after isoproterenol injection and β1/β2-adrenoceptor mRNA expression.